Stocks and Investing Stocks and Investing
Tue, January 14, 2020
Mon, January 13, 2020
Fri, January 10, 2020
Thu, January 9, 2020
Wed, January 8, 2020

Raghuram Selvaraju Maintained (BTAI) at Strong Buy with Increased Target to $30 on, Jan 8th, 2020


Published on 2024-10-26 19:47:54 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy with Increased Target from $25 to $30 on, Jan 8th, 2020.

Raghuram has made no other calls on BTAI in the last 4 months.



There is 1 other peer that has a rating on BTAI. Out of the 1 peers that are also analyzing BTAI, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Robyn Karnauskas of "SunTrust Robinson Humphrey" Initiated at Strong Buy and Held Target at $24 on, Tuesday, November 12th, 2019